Evidence map›Paper›PMID 27918223›Full record

ArticleOphthalmic epidemiology2016

Prevalence of Trachoma in Niger State, North Central Nigeria: Results of 25 Population-Based Prevalence Surveys Carried Out with the Global Trachoma Mapping Project.

Mohammed Dantani Adamu, Caleb Mpyet, Nasiru Muhammad, Murtala Muhammad Umar, Habila Muazu, Francisca Olamiju, Sunday Isiyaku, Uwazoeke Onyebuchi, Usman Abubakar Bosso, Adamani William and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in Ophthalmic epidemiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Prevalence of trachoma in Pernambuco State, Brazil (2014-2015).Revista do Instituto de Medicina Tropical de Sao Paulo · 2021
    Article
  6. Article
  7. Article
  8. The global burden of trichiasis in 2016.PLoS neglected tropical diseases · 2019
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 3 countries.

Mohammed Dantani Adamua Ophthalmology Unit, Surgery Department , Usmanu Danfodiyo University , Sokoto , Nigeria.
Caleb Mpyetb Sightsavers, Nigeria country office , Kaduna , Nigeria.
Nasiru Muhammada Ophthalmology Unit, Surgery Department , Usmanu Danfodiyo University , Sokoto , Nigeria.
Murtala Muhammad Umard National Eye Centre , Kaduna , Nigeria.
Habila Muazue Gambo Sawaba Hospital , Zaria , Nigeria.
Francisca Olamijuf Mission To Save The Helpless , Jos , Nigeria.
Sunday Isiyakub Sightsavers, Nigeria country office , Kaduna , Nigeria.
Uwazoeke Onyebuchig Federal Ministry of Health , Abuja , Nigeria.
Usman Abubakar Bossoh Ministry of Health , Niger State.
Adamani Williamb Sightsavers, Nigeria country office , Kaduna , Nigeria.
Benjamin C Nwobig Federal Ministry of Health , Abuja , Nigeria.
Rebecca Willisi Task Force for Global Health , Decatur, GA , USA.
Rebecca Mann Flueckigeri Task Force for Global Health , Decatur, GA , USA.
Alexandre Pavlucki Task Force for Global Health , Decatur, GA , USA.
Brian K Chui Task Force for Global Health , Decatur, GA , USA.
Nicholas Olobiog Federal Ministry of Health , Abuja , Nigeria.
Anthony W Solomonj Clinical Research Department , London School of Hygiene & Tropical Medicine , London , UK.
Global Trachoma Mapping Project
The Task Force for Global Health · USFederal Ministry of Health · NGUsmanu Danfodiyo University · NGLondon School of Hygiene & Tropical Medicine · GBNational Eye Centre · NGUniversity of Jos · NG

Funding

Wellcome TrustWellcome Trust 098521
6 · The paper itself

Abstract

purposeTo determine the prevalence of trachoma in each of the 25 local government areas (LGAs) of Niger State, Nigeria.

methodsA population-based cross-sectional survey was conducted in each Niger State LGA between March and April 2014, as part of the Global Trachoma Mapping Project (GTMP). GTMP protocols were used in planning and conduct of the surveys. Using probability proportional to size, 25 clusters were selected; in each of these clusters, 25 households were enrolled for the survey. All residents aged 1 year and older were examined by GTMP-certified graders for trachomatous inflammation - follicular (TF) and trichiasis using the World Health Organization simplified grading scheme. Additionally, we collected data on household water and sanitation facilities.

resultsOnly one LGA (Kontagora) had TF prevalence in 1-9-year-olds above 10%; one other LGA (Rafi) had TF prevalence between 5.0 and 9.9%. Six LGAs need trichiasis surgical services provided to achieve a prevalence of <1 case of trichiasis per 1000 total population. The proportion of households with access to improved water sources ranged from 23 to 100%, while household-level access to improved latrines ranged from 8 to 100% across the LGAs.

conclusionThe prevalence of trachoma is relatively low in most of Niger State. There is a need for community-based trichiasis surgical services in a small number of LGAs. The trachoma elimination program could engage water and sanitation agencies to augment access to improved water and sanitation facilities, for human rights reasons. Kontagora and Rafi need community-based interventions to reduce the prevalence of active trachoma.

Indexed as

AdolescentAdultAgedAged, 80 and overChildChild, PreschoolCross-Sectional StudiesFemaleHealth SurveysHumansHygieneInfantMaleMiddle AgedNigerPrevalenceEliminationepidemiologyGlobal Trachoma Mapping ProjectNigeriatrachomatrichiasis

Identifiers

PMID27918223
PMCPMC5706972
OpenAlexW2560127776

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.